EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.79 and traded as high as ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

Island community is coming together to support the family of four-year-old Jasper Danecke, who is being treated for leukemia ...

Paul Critchett battled Veterans Affairs for years, certain his terminal cancer diagnosis stemmed from radiation exposure. On ...

Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.